Straits Times Index
3,189.10 +34.41 (+1.09%) Nikkei
38,079.70 +117.90 (+0.31%) Hang Seng
16,385.87 +134.03 (+0.82%) FTSE 100
7,885.67 +37.68 (+0.48%) Bitcoin USD
61,466.56 -2,011.66 (-3.17%) CMC Crypto 200
885.54 0.00 (0.00%)
Gossamer Bio, Inc. (GOSS)
After hours:
| Previous close | 0.8208 |
| Open | 0.8293 |
| Bid | 0.8128 x 300 |
| Ask | 0.8484 x 300 |
| Day's range | 0.8000 - 0.8555 |
| 52-week range | 0.4530 - 1.8800 |
| Volume | |
| Avg. volume | 1,301,243 |
| Market cap | 184.977M |
| Beta (5Y monthly) | 1.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1800 |
| Earnings date | 07 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.72 |
Insider Monkey13 Best Biotech Stocks To Buy Under $20
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
Business WireGossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
SAN DIEGO, March 12, 2024--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced the appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors. Dr. Nathan is Medical Director of Inova’s Advanced Lung Disease Program and Lung Transplant
ZacksShould You Buy Gossamer Bio (GOSS) After Golden Cross?
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
